Olink® - Next Generation Proteomic Technology
Olink® HT
As an Olink® Certified Service Provider, AGRF joins a select group of laboratories globally recognised for their expertise and excellence in using Olink’s groundbreaking proteomic technology. Our local support ensures that Australian researchers have direct access to Olink® Explore HT and Explore 3072 state-of-the-art proteomic analysis platforms. This access enables researchers to seamlessly integrate protein-level data with genomic and transcriptomic information, fostering comprehensive and impactful studies and facilitating discoveries in disease biology, drug development and personalised medicine.
Olink® Explore
Olink Explore is engineered for exceptional performance in protein biomarker discovery, where you are conducting pilot studies with a few hundred samples or extensive population studies with biobank cohorts. With the introduction of Olink at AGRF, you now have the capability to accurately measure over 5,400 proteins simultaneously using a single plasma sample. This ground-breaking technology expands applications across various therapeutic areas and enhances our understanding of molecular pathways in disease development, progression, and outcome.
A uniquely powerful tool to determine protein causality in disease.
Identify actionable biomarkers.
Measure a dynamic range of the plasma proteome to deliver more insights at scale.
AGRF’s expertise and commitment to seamless genomic sequencing as we transition to new technologies.
Meet Benjamin Cooper, PhD Technical Officer in charge of the Olink platform at AGRF. Benjamin explains the new Olink technologies at AGRF.
